ID   UBC_HUMAN               Reviewed;         685 AA.
AC   P0CG48; P02248; P02249; P02250; P62988; Q29120; Q6LBL4; Q6LDU5;
AC   Q8WYN8; Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8;
AC   Q9UPK7;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2012, sequence version 3.
DT   22-JUL-2015, entry version 58.
DE   RecName: Full=Polyubiquitin-C;
DE   Contains:
DE     RecName: Full=Ubiquitin;
DE   Flags: Precursor;
GN   Name=UBC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2988935;
RA   Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A.,
RA   Vuust J.;
RT   "The human ubiquitin multigene family: some genes contain multiple
RT   directly repeated ubiquitin coding sequences.";
RL   EMBO J. 4:755-759(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9644242; DOI=10.1093/oxfordjournals.jbchem.a022093;
RA   Kim N.S., Yamaguchi T., Sekine S., Saeki M., Iwamuro S., Kato S.;
RT   "Cloning of human polyubiquitin cDNAs and a ubiquitin-binding assay
RT   involving its in vitro translation product.";
RL   J. Biochem. 124:35-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14745543; DOI=10.1007/s00239-003-2532-4;
RA   Tachikui H., Saitou N., Nakajima T., Hayasaka I., Ishida T., Inoue I.;
RT   "Lineage-specific homogenization of the polyubiquitin gene among human
RT   and great apes.";
RL   J. Mol. Evol. 57:737-744(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Liver, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-611.
RX   PubMed=8917096; DOI=10.1016/0378-1119(96)00145-X;
RA   Nenoi M., Mita K., Ichimura S., Cartwright I.L., Takahashi E.,
RA   Yamauchi M., Tsuji H.;
RT   "Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3
RT   cells.";
RL   Gene 175:179-185(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-74.
RX   PubMed=1128706; DOI=10.1038/255423a0;
RA   Schlesinger D.H., Goldstein G.;
RT   "Molecular conservation of 74 amino acid sequence of ubiquitin between
RT   cattle and man.";
RL   Nature 255:423-424(1975).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-27; 30-42 AND 55-72, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 1-27 AND 43-54, UBIQUITINATION AT LYS-6; LYS-11
RP   AND LYS-48, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16443603; DOI=10.1074/jbc.M512786200;
RA   Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J.;
RT   "Alzheimer disease-specific conformation of hyperphosphorylated paired
RT   helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and
RT   Lys-6 ubiquitin conjugation.";
RL   J. Biol. Chem. 281:10825-10838(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-685.
RX   PubMed=9504932;
RA   Nenoi M., Mita K., Ichimura S., Kawano A.;
RT   "Higher frequency of concerted evolutionary events in rodents than in
RT   man at the polyubiquitin gene VNTR locus.";
RL   Genetics 148:867-876(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 417-685.
RX   PubMed=2820408; DOI=10.1016/0006-291X(87)90970-3;
RA   Einspanier R., Sharma H.S., Scheit K.H.;
RT   "Cloning and sequence analysis of a cDNA encoding poly-ubiquitin in
RT   human ovarian granulosa cells.";
RL   Biochem. Biophys. Res. Commun. 147:581-587(1987).
RN   [12]
RP   FUNCTION, UBIQUITINATION AT LYS-11; LYS-29; LYS-48 AND LYS-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and
RT   degradation by multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [13]
RP   UBIQUITINATION AT LYS-27.
RX   PubMed=15466860; DOI=10.1074/jbc.M402916200;
RA   Okumura F., Hatakeyama S., Matsumoto M., Kamura T., Nakayama K.;
RT   "Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B
RT   contributes to neuritogenesis.";
RL   J. Biol. Chem. 279:53533-53543(2004).
RN   [14]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-48.
RC   TISSUE=Lung adenocarcinoma;
RX   PubMed=17203973; DOI=10.1021/pr060438j;
RA   Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,
RA   Haines D.S., Figeys D.;
RT   "The proteomic reactor facilitates the analysis of affinity-purified
RT   proteins by mass spectrometry: application for identifying
RT   ubiquitinated proteins in human cells.";
RL   J. Proteome Res. 6:298-305(2007).
RN   [15]
RP   UBIQUITINATION AT LYS-63, AND MUTAGENESIS OF LYS-48 AND LYS-63.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [16]
RP   REVIEW, AND FUNCTION.
RX   PubMed=19754430; DOI=10.1042/BST0370937;
RA   Komander D.;
RT   "The emerging complexity of protein ubiquitination.";
RL   Biochem. Soc. Trans. 37:937-953(2009).
RN   [17]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24660806; DOI=10.1042/BJ20140334;
RA   Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G.,
RA   Ritorto M.S., Hofmann K., Alessi D.R., Knebel A., Trost M.,
RA   Muqit M.M.;
RT   "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin
RT   at Ser65.";
RL   Biochem. J. 460:127-139(2014).
RN   [18]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24751536; DOI=10.1083/jcb.201402104;
RA   Kane L.A., Lazarou M., Fogel A.I., Li Y., Yamano K., Sarraf S.A.,
RA   Banerjee S., Youle R.J.;
RT   "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase
RT   activity.";
RL   J. Cell Biol. 205:143-153(2014).
RN   [19]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24784582; DOI=10.1038/nature13392;
RA   Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M.,
RA   Kimura Y., Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A.,
RA   Trempe J.F., Saeki Y., Tanaka K., Matsuda N.;
RT   "Ubiquitin is phosphorylated by PINK1 to activate parkin.";
RL   Nature 510:162-166(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=3041007; DOI=10.1016/0022-2836(87)90679-6;
RA   Vijay-Kumar S., Bugg C.E., Cook W.J.;
RT   "Structure of ubiquitin refined at 1.8-A resolution.";
RL   J. Mol. Biol. 194:531-544(1987).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8166633;
RA   Ramage R., Green J., Muir T.W., Ogunjobi O.M., Love S., Shaw K.;
RT   "Synthetic, structural and biological studies of the ubiquitin system:
RT   the total chemical synthesis of ubiquitin.";
RL   Biochem. J. 299:151-158(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8107144; DOI=10.1006/jmbi.1994.1169;
RA   Cook W.J., Jeffrey L.C., Kasperek E., Pickart C.M.;
RT   "Structure of tetraubiquitin shows how multiubiquitin chains can be
RT   formed.";
RL   J. Mol. Biol. 236:601-609(1994).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=11173499; DOI=10.1107/S090744490001800X;
RA   Phillips C.L., Thrower J., Pickart C.M., Hill C.P.;
RT   "Structure of a new crystal form of tetraubiquitin.";
RL   Acta Crystallogr. D 57:341-344(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP7.
RX   PubMed=12507430; DOI=10.1016/S0092-8674(02)01199-6;
RA   Hu M., Li P., Li M., Li W., Yao T., Wu J.-W., Gu W., Cohen R.E.,
RA   Shi Y.;
RT   "Crystal structure of a UBP-family deubiquitinating enzyme in
RT   isolation and in complex with ubiquitin aldehyde.";
RL   Cell 111:1041-1054(2002).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP21.
RX   PubMed=21399617; DOI=10.1038/embor.2011.17;
RA   Ye Y., Akutsu M., Reyes-Turcu F., Enchev R.I., Wilkinson K.D.,
RA   Komander D.;
RT   "Polyubiquitin binding and cross-reactivity in the USP domain
RT   deubiquitinase USP21.";
RL   EMBO Rep. 12:350-357(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-76.
RX   PubMed=20622874; DOI=10.1038/nsmb.1873;
RA   Bremm A., Freund S.M., Komander D.;
RT   "Lys11-linked ubiquitin chains adopt compact conformations and are
RT   preferentially hydrolyzed by the deubiquitinase Cezanne.";
RL   Nat. Struct. Mol. Biol. 17:939-947(2010).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 1-76 IN COMPLEX WITH YOD1.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F.,
RA   Freund S.M., Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and
RT   enable ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 153-228 PHOSPHORYLATED AT
RP   SER-65, AND PHOSPHORYLATION AT SER-65.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
CC   -!- FUNCTION: Ubiquitin: Exists either covalently attached to another
CC       protein, or free (unanchored). When covalently bound, it is
CC       conjugated to target proteins via an isopeptide bond either as a
CC       monomer (monoubiquitin), a polymer linked via different Lys
CC       residues of the ubiquitin (polyubiquitin chains) or a linear
CC       polymer linked via the initiator Met of the ubiquitin (linear
CC       polyubiquitin chains). Polyubiquitin chains, when attached to a
CC       target protein, have different functions depending on the Lys
CC       residue of the ubiquitin that is linked: Lys-6-linked may be
CC       involved in DNA repair; Lys-11-linked is involved in ERAD
CC       (endoplasmic reticulum-associated degradation) and in cell-cycle
CC       regulation; Lys-29-linked is involved in lysosomal degradation;
CC       Lys-33-linked is involved in kinase modification; Lys-48-linked is
CC       involved in protein degradation via the proteasome; Lys-63-linked
CC       is involved in endocytosis, DNA-damage responses as well as in
CC       signaling processes leading to activation of the transcription
CC       factor NF-kappa-B. Linear polymer chains formed via attachment by
CC       the initiator Met lead to cell signaling. Ubiquitin is usually
CC       conjugated to Lys residues of target proteins, however, in rare
CC       cases, conjugation to Cys or Ser residues has been observed. When
CC       polyubiquitin is free (unanchored-polyubiquitin), it also has
CC       distinct roles, such as in activation of protein kinases, and in
CC       signaling. {ECO:0000269|PubMed:16543144,
CC       ECO:0000269|PubMed:19754430}.
CC   -!- INTERACTION:
CC       Q9UNQ0:ABCG2; NbExp=2; IntAct=EBI-3390054, EBI-1569435;
CC       P25098:ADRBK1; NbExp=3; IntAct=EBI-3390054, EBI-3904795;
CC       Q16186:ADRM1; NbExp=10; IntAct=EBI-3390054, EBI-954387;
CC       Q9ULH1:ASAP1; NbExp=2; IntAct=EBI-3390054, EBI-346622;
CC       O43150:ASAP2; NbExp=2; IntAct=EBI-3390054, EBI-310968;
CC       P54252:ATXN3; NbExp=2; IntAct=EBI-3390054, EBI-946046;
CC       Q9HB09-1:BCL2L12; NbExp=3; IntAct=EBI-3390054, EBI-6968951;
CC       P35226:BMI1; NbExp=2; IntAct=EBI-3390054, EBI-2341576;
CC       O60566:BUB1B; NbExp=3; IntAct=EBI-3390054, EBI-1001438;
CC       P06493:CDK1; NbExp=6; IntAct=EBI-3390054, EBI-444308;
CC       Q99062:CSF3R; NbExp=2; IntAct=EBI-3390054, EBI-7331284;
CC       Q9UER7:DAXX; NbExp=2; IntAct=EBI-3390054, EBI-77321;
CC       P40087:DDI1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-5717;
CC       O43583:DENR; NbExp=3; IntAct=EBI-3390054, EBI-716083;
CC       P48510:DSK2 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-6174;
CC       Q86Y01:DTX1; NbExp=2; IntAct=EBI-3390054, EBI-1755174;
CC       Q15717:ELAVL1; NbExp=4; IntAct=EBI-3390054, EBI-374260;
CC       Q61088:Fzd4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7987880;
CC       Q9Y6K9:IKBKG; NbExp=4; IntAct=EBI-3390054, EBI-81279;
CC       O88522:Ikbkg (xeno); NbExp=3; IntAct=EBI-3390054, EBI-998011;
CC       Q13887:KLF5; NbExp=2; IntAct=EBI-3390054, EBI-2696013;
CC       P06239:LCK; NbExp=2; IntAct=EBI-3390054, EBI-1348;
CC       P48357-3:LEPR; NbExp=2; IntAct=EBI-3390054, EBI-7886448;
CC       Q9UDY8:MALT1; NbExp=4; IntAct=EBI-3390054, EBI-1047372;
CC       Q9Y6R4:MAP3K4; NbExp=2; IntAct=EBI-3390054, EBI-448104;
CC       O43318:MAP3K7; NbExp=4; IntAct=EBI-3390054, EBI-358684;
CC       Q9NX47:MARCH5; NbExp=2; IntAct=EBI-3390054, EBI-2341610;
CC       Q00987:MDM2; NbExp=6; IntAct=EBI-3390054, EBI-389668;
CC       P01106:MYC; NbExp=5; IntAct=EBI-3390054, EBI-447544;
CC       O43639:NCK2; NbExp=2; IntAct=EBI-3390054, EBI-713635;
CC       Q14934:NFATC4; NbExp=3; IntAct=EBI-3390054, EBI-3905796;
CC       P25963:NFKBIA; NbExp=3; IntAct=EBI-3390054, EBI-307386;
CC       P09874:PARP1; NbExp=2; IntAct=EBI-3390054, EBI-355676;
CC       P35227:PCGF2; NbExp=2; IntAct=EBI-3390054, EBI-2129767;
CC       Q9Y253:POLH; NbExp=4; IntAct=EBI-3390054, EBI-2827270;
CC       Q9UNA4:POLI; NbExp=4; IntAct=EBI-3390054, EBI-741774;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3390054, EBI-1383528;
CC       P55036:PSMD4; NbExp=8; IntAct=EBI-3390054, EBI-359318;
CC       P32628:RAD23 (xeno); NbExp=4; IntAct=EBI-3390054, EBI-14668;
CC       P54727:RAD23B; NbExp=4; IntAct=EBI-3390054, EBI-954531;
CC       Q84L31:RAD23C (xeno); NbExp=2; IntAct=EBI-3390054, EBI-4437395;
CC       P61224:RAP1B; NbExp=2; IntAct=EBI-3390054, EBI-358143;
CC       Q62921:Rbck1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7266339;
CC       Q96NR8:RDH12; NbExp=2; IntAct=EBI-3390054, EBI-3916363;
CC       Q04206:RELA; NbExp=6; IntAct=EBI-3390054, EBI-73886;
CC       P04325:rev (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7061954;
CC       P55034:RPN10 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-2620423;
CC       O48726:RPN13 (xeno); NbExp=9; IntAct=EBI-3390054, EBI-7710745;
CC       Q8N488:RYBP; NbExp=3; IntAct=EBI-3390054, EBI-752324;
CC       Q9H4L4:SENP3; NbExp=2; IntAct=EBI-3390054, EBI-2880236;
CC       Q96B97:SH3KBP1; NbExp=6; IntAct=EBI-3390054, EBI-346595;
CC       Q9Y5X1:SNX9; NbExp=2; IntAct=EBI-3390054, EBI-77848;
CC       Q13501:SQSTM1; NbExp=3; IntAct=EBI-3390054, EBI-307104;
CC       Q92783:STAM; NbExp=2; IntAct=EBI-3390054, EBI-752333;
CC       Q86VP1:TAX1BP1; NbExp=5; IntAct=EBI-3390054, EBI-529518;
CC       P04637:TP53; NbExp=15; IntAct=EBI-3390054, EBI-366083;
CC       Q9Y4K3:TRAF6; NbExp=3; IntAct=EBI-3390054, EBI-359276;
CC       Q9EPK8:Trpv4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7091763;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-3390054, EBI-741480;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-3390054, EBI-517127;
CC       O76080:ZFAND5; NbExp=3; IntAct=EBI-3390054, EBI-8028844;
CC       Q9UGI0:ZRANB1; NbExp=2; IntAct=EBI-3390054, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Ubiquitin: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitin: Phosphorylated at Ser-65 by PINK1 during
CC       mitophagy. Phosphorylated ubiquitin specifically binds and
CC       activates parkin (PARK2), triggering mitophagy (PubMed:24660806,
CC       PubMed:24751536, PubMed:24784582, PubMed:25527291).
CC       Phosphorylation does not affect E1-mediated E2 charging of
CC       ubiquitin but affects discharging of E2 enzymes to form
CC       polyubiquitin chains. It also affects deubiquitination by
CC       deubiquitinase enzymes such as USP30 (PubMed:25527291).
CC       {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536,
CC       ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
CC   -!- MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. UBA52
CC       and RPS27A genes code for a single copy of ubiquitin fused to the
CC       ribosomal proteins L40 and S27a, respectively. UBB and UBC genes
CC       code for a polyubiquitin precursor with exact head to tail
CC       repeats, the number of repeats differ between species and strains.
CC   -!- MISCELLANEOUS: For the sake of clarity sequence features are
CC       annotated only for the first chain, and are not repeated for each
CC       of the following chains.
CC   -!- SIMILARITY: Belongs to the ubiquitin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 9 ubiquitin-like domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00214}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26880; AAA36789.1; -; mRNA.
DR   EMBL; AB009010; BAA23632.1; -; mRNA.
DR   EMBL; AB089613; BAC56951.1; -; Genomic_DNA.
DR   EMBL; AC126309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039193; AAH39193.1; -; mRNA.
DR   EMBL; D63791; BAA09860.1; -; Genomic_DNA.
DR   EMBL; AB003730; BAA23486.1; -; Genomic_DNA.
DR   EMBL; M17597; AAA36787.1; -; mRNA.
DR   CCDS; CCDS9260.1; -.
DR   PIR; A02574; UQHU.
DR   PIR; A22005; UQHUC.
DR   PIR; A29526; A29526.
DR   RefSeq; NP_066289.3; NM_021009.6.
DR   UniGene; Hs.520348; -.
DR   UniGene; Hs.707528; -.
DR   PDB; 1C3T; NMR; -; A=1-76.
DR   PDB; 1CMX; X-ray; 2.25 A; B/D=1-76.
DR   PDB; 1D3Z; NMR; -; A=1-76.
DR   PDB; 1F9J; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 1FXT; NMR; -; B=1-76.
DR   PDB; 1G6J; NMR; -; A=1-76.
DR   PDB; 1GJZ; NMR; -; A/B=1-51.
DR   PDB; 1NBF; X-ray; 2.30 A; C/D=1-76.
DR   PDB; 1OGW; X-ray; 1.32 A; A=1-76.
DR   PDB; 1Q5W; NMR; -; B=1-76.
DR   PDB; 1S1Q; X-ray; 2.00 A; B/D=1-76.
DR   PDB; 1SIF; X-ray; 2.18 A; A=6-76.
DR   PDB; 1TBE; X-ray; 2.40 A; A/B=1-76.
DR   PDB; 1UBI; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UBQ; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UD7; NMR; -; A=1-76.
DR   PDB; 1XD3; X-ray; 1.45 A; B/D=1-75.
DR   PDB; 1XQQ; NMR; -; A=1-76.
DR   PDB; 1YX5; NMR; -; B=1-76.
DR   PDB; 1YX6; NMR; -; B=1-76.
DR   PDB; 1ZGU; NMR; -; B=1-76.
DR   PDB; 1ZO6; Model; -; B/C=1-76.
DR   PDB; 2AYO; X-ray; 3.50 A; B=1-76.
DR   PDB; 2BGF; NMR; -; A/B=1-76.
DR   PDB; 2DEN; NMR; -; B=1-76.
DR   PDB; 2FUH; NMR; -; B=1-76.
DR   PDB; 2G45; X-ray; 1.99 A; B/E=1-76.
DR   PDB; 2GBJ; X-ray; 1.35 A; A/B=1-76.
DR   PDB; 2GBK; X-ray; 1.99 A; A/B/C/D=10-76.
DR   PDB; 2GBM; X-ray; 1.55 A; A/B/C/D=1-76.
DR   PDB; 2GBN; X-ray; 1.60 A; A=1-76.
DR   PDB; 2GBR; X-ray; 2.00 A; A/B/C=1-76.
DR   PDB; 2GMI; X-ray; 2.50 A; C=1-76.
DR   PDB; 2HTH; X-ray; 2.70 A; A=1-76.
DR   PDB; 2IBI; X-ray; 2.20 A; B=1-75.
DR   PDB; 2J7Q; X-ray; 1.80 A; B/D=1-75.
DR   PDB; 2JF5; X-ray; 1.95 A; A/B=1-76.
DR   PDB; 2JRI; NMR; -; B/C=1-76.
DR   PDB; 2JY6; NMR; -; A=1-76.
DR   PDB; 2JZZ; NMR; -; A=1-76.
DR   PDB; 2K25; NMR; -; A=1-75.
DR   PDB; 2K6D; NMR; -; B=1-75.
DR   PDB; 2K8B; NMR; -; A=1-76.
DR   PDB; 2K8C; NMR; -; A=1-76.
DR   PDB; 2KDF; NMR; -; B/C=1-76.
DR   PDB; 2KHW; NMR; -; B=1-76.
DR   PDB; 2KJH; NMR; -; B=1-75.
DR   PDB; 2KLG; NMR; -; A=1-76.
DR   PDB; 2KN5; NMR; -; A=1-76.
DR   PDB; 2KX0; NMR; -; A=74-151.
DR   PDB; 2L3Z; NMR; -; A=1-76.
DR   PDB; 2LD9; NMR; -; A=76-152.
DR   PDB; 2LVO; NMR; -; A=1-76.
DR   PDB; 2LVP; NMR; -; A/B=1-76.
DR   PDB; 2LVQ; NMR; -; A/B=1-76.
DR   PDB; 2LZ6; NMR; -; A=609-684.
DR   PDB; 2MBO; NMR; -; A/B=609-684.
DR   PDB; 2MBQ; NMR; -; A/B=609-684.
DR   PDB; 2MCN; NMR; -; B=609-684.
DR   PDB; 2MI8; NMR; -; A=609-684.
DR   PDB; 2MJ5; NMR; -; A=609-684.
DR   PDB; 2MOR; NMR; -; A=609-684.
DR   PDB; 2MRE; NMR; -; A=609-684.
DR   PDB; 2MWS; NMR; -; A=609-684.
DR   PDB; 2NR2; NMR; -; A=1-76.
DR   PDB; 2O6V; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 2OJR; X-ray; 2.60 A; A=1-76.
DR   PDB; 2PE9; NMR; -; A/B=1-76.
DR   PDB; 2PEA; NMR; -; A/B=1-76.
DR   PDB; 2RR9; NMR; -; A/B=1-76.
DR   PDB; 2RU6; NMR; -; A=609-684.
DR   PDB; 2W9N; X-ray; 2.25 A; A=1-152.
DR   PDB; 2WDT; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 2XEW; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L=1-76.
DR   PDB; 2Y5B; X-ray; 2.70 A; B/F=1-152.
DR   PDB; 2Z59; NMR; -; B=1-76.
DR   PDB; 2ZCB; X-ray; 1.60 A; A/B/C=1-76.
DR   PDB; 2ZVN; X-ray; 3.00 A; A/C/E/G=1-152.
DR   PDB; 2ZVO; X-ray; 2.90 A; A/G=1-152.
DR   PDB; 3A33; X-ray; 2.20 A; B=1-76.
DR   PDB; 3ALB; X-ray; 1.85 A; A/B/C/D=1-76.
DR   PDB; 3AUL; X-ray; 2.39 A; A/B=1-76.
DR   PDB; 3B08; X-ray; 1.70 A; A/D/G/J=1-152.
DR   PDB; 3B0A; X-ray; 1.90 A; A/D=1-152.
DR   PDB; 3BY4; X-ray; 1.55 A; B=1-75.
DR   PDB; 3C0R; X-ray; 2.31 A; B/D=1-75.
DR   PDB; 3DVG; X-ray; 2.60 A; X/Y=1-76.
DR   PDB; 3DVN; X-ray; 2.70 A; U/V/X/Y=1-76.
DR   PDB; 3EEC; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3EFU; X-ray; 1.84 A; A=1-76.
DR   PDB; 3EHV; X-ray; 1.81 A; A/B/C=1-76.
DR   PDB; 3H7P; X-ray; 1.90 A; A/B=1-76.
DR   PDB; 3H7S; X-ray; 2.30 A; A/B=1-76.
DR   PDB; 3HM3; X-ray; 1.96 A; A/B/C/D=1-76.
DR   PDB; 3I3T; X-ray; 2.59 A; B/D/F/H=1-75.
DR   PDB; 3IFW; X-ray; 2.40 A; B=1-75.
DR   PDB; 3IHP; X-ray; 2.80 A; C/D=1-75.
DR   PDB; 3JSV; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 3JVZ; X-ray; 3.30 A; X/Y=1-76.
DR   PDB; 3JW0; X-ray; 3.10 A; X/Y=1-76.
DR   PDB; 3K9O; X-ray; 1.80 A; B=76-151.
DR   PDB; 3K9P; X-ray; 2.80 A; B=1-76.
DR   PDB; 3KVF; X-ray; 2.80 A; B=1-75.
DR   PDB; 3KW5; X-ray; 2.83 A; B=1-75.
DR   PDB; 3LDZ; X-ray; 2.60 A; E/F/G=1-73.
DR   PDB; 3MHS; X-ray; 1.89 A; D=1-76.
DR   PDB; 3MTN; X-ray; 2.70 A; B/D=1-76.
DR   PDB; 3N30; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3N32; X-ray; 1.80 A; A=1-76.
DR   PDB; 3N3K; X-ray; 2.60 A; B=5-76.
DR   PDB; 3NS8; X-ray; 1.71 A; A/B=1-76.
DR   PDB; 3O65; X-ray; 2.70 A; B/D/F/H=1-75.
DR   PDB; 3OFI; X-ray; 2.35 A; C/D=1-76.
DR   PDB; 3OJ3; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 3OJ4; X-ray; 3.40 A; B/E=1-76.
DR   PDB; 3ONS; X-ray; 1.80 A; A=1-72.
DR   PDB; 3PRM; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 3PT2; X-ray; 2.50 A; B=1-75.
DR   PDB; 3PTF; X-ray; 2.70 A; C/D=1-76.
DR   PDB; 3Q3F; X-ray; 2.17 A; A=2-76.
DR   PDB; 3RUL; X-ray; 2.50 A; A/B/C/D=1-75.
DR   PDB; 3TMP; X-ray; 1.91 A; B/D/F/H=1-76.
DR   PDB; 3U30; X-ray; 2.43 A; A/D=1-152.
DR   PDB; 3UGB; X-ray; 2.35 A; B=1-76.
DR   PDB; 3V6C; X-ray; 1.70 A; B=74-150.
DR   PDB; 3V6E; X-ray; 2.10 A; B=74-150.
DR   PDB; 3VFK; X-ray; 2.80 A; A=1-75.
DR   PDB; 3VUW; X-ray; 1.95 A; A/B/C=1-76.
DR   PDB; 3VUX; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 3VUY; X-ray; 1.98 A; A/B/C=1-76.
DR   PDB; 3WXE; X-ray; 2.50 A; B=533-680.
DR   PDB; 3WXF; X-ray; 2.30 A; B/D=533-680.
DR   PDB; 3ZLZ; X-ray; 2.90 A; A/B=1-76.
DR   PDB; 3ZNH; X-ray; 2.30 A; B=1-75.
DR   PDB; 3ZNI; X-ray; 2.21 A; D/H/L/P=1-76.
DR   PDB; 3ZNZ; X-ray; 1.90 A; B=1-152.
DR   PDB; 4AUQ; X-ray; 2.18 A; C/F=1-76.
DR   PDB; 4BOS; X-ray; 2.35 A; C/E=609-684, F=612-625.
DR   PDB; 4BOZ; X-ray; 3.03 A; B/C/E=1-76.
DR   PDB; 4BVU; X-ray; 2.70 A; C=609-684.
DR   PDB; 4DDG; X-ray; 3.30 A; D/E/F/G/H/I/M/N/O/P/Q/R=1-76.
DR   PDB; 4DDI; X-ray; 3.80 A; G/H/I/J/K/L=1-76.
DR   PDB; 4DHJ; X-ray; 2.35 A; B/F/J/M=1-76, D/H=1-75.
DR   PDB; 4DHZ; X-ray; 3.11 A; B=1-76, E=1-75.
DR   PDB; 4FJV; X-ray; 2.05 A; B/D=1-76.
DR   PDB; 4HK2; X-ray; 1.40 A; A/B/C/D=1-76.
DR   PDB; 4HXD; X-ray; 2.85 A; A/C=1-75.
DR   PDB; 4I6L; X-ray; 2.49 A; B=77-150.
DR   PDB; 4I6N; X-ray; 1.70 A; B/D=1-75.
DR   PDB; 4IG7; X-ray; 2.00 A; B=1-75.
DR   PDB; 4IUM; X-ray; 1.45 A; B=1-75.
DR   PDB; 4JQW; X-ray; 2.90 A; C=609-684.
DR   PDB; 4K1R; X-ray; 1.63 A; B/D=607-684.
DR   PDB; 4K7S; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7U; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7W; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4KSK; X-ray; 2.40 A; C/D=76-152.
DR   PDB; 4KSL; X-ray; 2.83 A; C/D/F/H/J/L/N/P/R/T/V/X=76-228.
DR   PDB; 4LCD; X-ray; 3.10 A; E/F=609-683.
DR   PDB; 4LDT; X-ray; 1.90 A; B/D=609-684.
DR   PDB; 4MDK; X-ray; 2.61 A; E/F/G/H=608-684.
DR   PDB; 4MM3; X-ray; 2.75 A; A=609-684.
DR   PDB; 4MSM; X-ray; 1.74 A; B/D=609-684.
DR   PDB; 4MSQ; X-ray; 1.95 A; B/D=609-684.
DR   PDB; 4NQK; X-ray; 3.70 A; E/F/G/H/I/J=608-684.
DR   PDB; 4UN2; X-ray; 1.51 A; A=609-684.
DR   PDB; 4V3K; X-ray; 2.04 A; B/E=609-684.
DR   PDB; 4V3L; X-ray; 1.53 A; B/D=609-684.
DR   PDB; 4WZP; X-ray; 1.90 A; A/B/C/D/E/F/G/H=153-228.
DR   PDBsum; 1C3T; -.
DR   PDBsum; 1CMX; -.
DR   PDBsum; 1D3Z; -.
DR   PDBsum; 1F9J; -.
DR   PDBsum; 1FXT; -.
DR   PDBsum; 1G6J; -.
DR   PDBsum; 1GJZ; -.
DR   PDBsum; 1NBF; -.
DR   PDBsum; 1OGW; -.
DR   PDBsum; 1Q5W; -.
DR   PDBsum; 1S1Q; -.
DR   PDBsum; 1SIF; -.
DR   PDBsum; 1TBE; -.
DR   PDBsum; 1UBI; -.
DR   PDBsum; 1UBQ; -.
DR   PDBsum; 1UD7; -.
DR   PDBsum; 1XD3; -.
DR   PDBsum; 1XQQ; -.
DR   PDBsum; 1YX5; -.
DR   PDBsum; 1YX6; -.
DR   PDBsum; 1ZGU; -.
DR   PDBsum; 1ZO6; -.
DR   PDBsum; 2AYO; -.
DR   PDBsum; 2BGF; -.
DR   PDBsum; 2DEN; -.
DR   PDBsum; 2FUH; -.
DR   PDBsum; 2G45; -.
DR   PDBsum; 2GBJ; -.
DR   PDBsum; 2GBK; -.
DR   PDBsum; 2GBM; -.
DR   PDBsum; 2GBN; -.
DR   PDBsum; 2GBR; -.
DR   PDBsum; 2GMI; -.
DR   PDBsum; 2HTH; -.
DR   PDBsum; 2IBI; -.
DR   PDBsum; 2J7Q; -.
DR   PDBsum; 2JF5; -.
DR   PDBsum; 2JRI; -.
DR   PDBsum; 2JY6; -.
DR   PDBsum; 2JZZ; -.
DR   PDBsum; 2K25; -.
DR   PDBsum; 2K6D; -.
DR   PDBsum; 2K8B; -.
DR   PDBsum; 2K8C; -.
DR   PDBsum; 2KDF; -.
DR   PDBsum; 2KHW; -.
DR   PDBsum; 2KJH; -.
DR   PDBsum; 2KLG; -.
DR   PDBsum; 2KN5; -.
DR   PDBsum; 2KX0; -.
DR   PDBsum; 2L3Z; -.
DR   PDBsum; 2LD9; -.
DR   PDBsum; 2LVO; -.
DR   PDBsum; 2LVP; -.
DR   PDBsum; 2LVQ; -.
DR   PDBsum; 2LZ6; -.
DR   PDBsum; 2MBO; -.
DR   PDBsum; 2MBQ; -.
DR   PDBsum; 2MCN; -.
DR   PDBsum; 2MI8; -.
DR   PDBsum; 2MJ5; -.
DR   PDBsum; 2MOR; -.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MWS; -.
DR   PDBsum; 2NR2; -.
DR   PDBsum; 2O6V; -.
DR   PDBsum; 2OJR; -.
DR   PDBsum; 2PE9; -.
DR   PDBsum; 2PEA; -.
DR   PDBsum; 2RR9; -.
DR   PDBsum; 2RU6; -.
DR   PDBsum; 2W9N; -.
DR   PDBsum; 2WDT; -.
DR   PDBsum; 2XEW; -.
DR   PDBsum; 2Y5B; -.
DR   PDBsum; 2Z59; -.
DR   PDBsum; 2ZCB; -.
DR   PDBsum; 2ZVN; -.
DR   PDBsum; 2ZVO; -.
DR   PDBsum; 3A33; -.
DR   PDBsum; 3ALB; -.
DR   PDBsum; 3AUL; -.
DR   PDBsum; 3B08; -.
DR   PDBsum; 3B0A; -.
DR   PDBsum; 3BY4; -.
DR   PDBsum; 3C0R; -.
DR   PDBsum; 3DVG; -.
DR   PDBsum; 3DVN; -.
DR   PDBsum; 3EEC; -.
DR   PDBsum; 3EFU; -.
DR   PDBsum; 3EHV; -.
DR   PDBsum; 3H7P; -.
DR   PDBsum; 3H7S; -.
DR   PDBsum; 3HM3; -.
DR   PDBsum; 3I3T; -.
DR   PDBsum; 3IFW; -.
DR   PDBsum; 3IHP; -.
DR   PDBsum; 3JSV; -.
DR   PDBsum; 3JVZ; -.
DR   PDBsum; 3JW0; -.
DR   PDBsum; 3K9O; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 3KVF; -.
DR   PDBsum; 3KW5; -.
DR   PDBsum; 3LDZ; -.
DR   PDBsum; 3MHS; -.
DR   PDBsum; 3MTN; -.
DR   PDBsum; 3N30; -.
DR   PDBsum; 3N32; -.
DR   PDBsum; 3N3K; -.
DR   PDBsum; 3NS8; -.
DR   PDBsum; 3O65; -.
DR   PDBsum; 3OFI; -.
DR   PDBsum; 3OJ3; -.
DR   PDBsum; 3OJ4; -.
DR   PDBsum; 3ONS; -.
DR   PDBsum; 3PRM; -.
DR   PDBsum; 3PT2; -.
DR   PDBsum; 3PTF; -.
DR   PDBsum; 3Q3F; -.
DR   PDBsum; 3RUL; -.
DR   PDBsum; 3TMP; -.
DR   PDBsum; 3U30; -.
DR   PDBsum; 3UGB; -.
DR   PDBsum; 3V6C; -.
DR   PDBsum; 3V6E; -.
DR   PDBsum; 3VFK; -.
DR   PDBsum; 3VUW; -.
DR   PDBsum; 3VUX; -.
DR   PDBsum; 3VUY; -.
DR   PDBsum; 3WXE; -.
DR   PDBsum; 3WXF; -.
DR   PDBsum; 3ZLZ; -.
DR   PDBsum; 3ZNH; -.
DR   PDBsum; 3ZNI; -.
DR   PDBsum; 3ZNZ; -.
DR   PDBsum; 4AUQ; -.
DR   PDBsum; 4BOS; -.
DR   PDBsum; 4BOZ; -.
DR   PDBsum; 4BVU; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4DDI; -.
DR   PDBsum; 4DHJ; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4FJV; -.
DR   PDBsum; 4HK2; -.
DR   PDBsum; 4HXD; -.
DR   PDBsum; 4I6L; -.
DR   PDBsum; 4I6N; -.
DR   PDBsum; 4IG7; -.
DR   PDBsum; 4IUM; -.
DR   PDBsum; 4JQW; -.
DR   PDBsum; 4K1R; -.
DR   PDBsum; 4K7S; -.
DR   PDBsum; 4K7U; -.
DR   PDBsum; 4K7W; -.
DR   PDBsum; 4KSK; -.
DR   PDBsum; 4KSL; -.
DR   PDBsum; 4LCD; -.
DR   PDBsum; 4LDT; -.
DR   PDBsum; 4MDK; -.
DR   PDBsum; 4MM3; -.
DR   PDBsum; 4MSM; -.
DR   PDBsum; 4MSQ; -.
DR   PDBsum; 4NQK; -.
DR   PDBsum; 4UN2; -.
DR   PDBsum; 4V3K; -.
DR   PDBsum; 4V3L; -.
DR   PDBsum; 4WZP; -.
DR   ProteinModelPortal; P0CG48; -.
DR   SMR; P0CG48; 1-683.
DR   BioGrid; 113164; 1406.
DR   IntAct; P0CG48; 167.
DR   MINT; MINT-97475; -.
DR   STRING; 9606.ENSP00000344818; -.
DR   PhosphoSite; P0CG48; -.
DR   DMDM; 391358178; -.
DR   PRIDE; P0CG48; -.
DR   Ensembl; ENST00000339647; ENSP00000344818; ENSG00000150991.
DR   Ensembl; ENST00000536769; ENSP00000441543; ENSG00000150991.
DR   GeneID; 7316; -.
DR   KEGG; hsa:7316; -.
DR   UCSC; uc001ugs.4; human.
DR   CTD; 7316; -.
DR   GeneCards; GC12M125396; -.
DR   HGNC; HGNC:12468; UBC.
DR   HPA; CAB000362; -.
DR   HPA; CAB005419; -.
DR   HPA; HPA041344; -.
DR   HPA; HPA049132; -.
DR   MIM; 191340; gene.
DR   neXtProt; NX_P0CG48; -.
DR   GeneTree; ENSGT00800000124094; -.
DR   InParanoid; P0CG48; -.
DR   KO; K08770; -.
DR   OMA; TTINIKY; -.
DR   OrthoDB; EOG7JDR1W; -.
DR   TreeFam; TF354256; -.
DR   Reactome; REACT_11063; Degradation of beta-catenin by the destruction complex.
DR   Reactome; REACT_111080; Spry regulation of FGF signaling.
DR   Reactome; REACT_111178; ER-Phagosome pathway.
DR   Reactome; REACT_1156; Orc1 removal from chromatin.
DR   Reactome; REACT_115662; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; REACT_115755; Signaling by ERBB2.
DR   Reactome; REACT_115828; Downregulation of ERBB4 signaling.
DR   Reactome; REACT_115831; ISG15 antiviral mechanism.
DR   Reactome; REACT_115852; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; REACT_115893; Membrane binding and targetting of GAG proteins.
DR   Reactome; REACT_1181; Association of licensing factors with the pre-replicative complex.
DR   Reactome; REACT_118614; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; REACT_118656; Activation of NF-kappaB in B cells.
DR   Reactome; REACT_118780; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; REACT_120726; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; REACT_120727; Downregulation of TGF-beta receptor signaling.
DR   Reactome; REACT_120734; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; REACT_120916; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; REACT_121111; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; REACT_1221; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; REACT_12484; EGFR downregulation.
DR   Reactome; REACT_12555; Downstream TCR signaling.
DR   Reactome; REACT_1287; Translesion Synthesis by POLH.
DR   Reactome; REACT_13415; p75NTR recruits signalling complexes.
DR   Reactome; REACT_13464; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; REACT_13643; NRIF signals cell death from the nucleus.
DR   Reactome; REACT_13696; NF-kB is activated and signals survival.
DR   Reactome; REACT_150471; Separation of Sister Chromatids.
DR   Reactome; REACT_160089; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; REACT_160189; Stimuli-sensing channels.
DR   Reactome; REACT_160205; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; REACT_160243; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; REACT_160254; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; REACT_160315; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; REACT_1614; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; REACT_163977; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; REACT_163994; FCERI mediated NF-kB activation.
DR   Reactome; REACT_169168; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; REACT_169208; Glycogen synthesis.
DR   Reactome; REACT_169325; Oncogene Induced Senescence.
DR   Reactome; REACT_169436; Oxidative Stress Induced Senescence.
DR   Reactome; REACT_18265; Regulation of the Fanconi anemia pathway.
DR   Reactome; REACT_18410; Fanconi Anemia pathway.
DR   Reactome; REACT_188323; CLEC7A (Dectin-1) signaling.
DR   Reactome; REACT_188330; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; REACT_1949; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; REACT_20549; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; REACT_21281; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; REACT_21368; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; REACT_21399; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; REACT_22442; Interleukin-1 signaling.
DR   Reactome; REACT_23787; Regulation of signaling by CBL.
DR   Reactome; REACT_24918; IRAK1 recruits IKK complex.
DR   Reactome; REACT_24941; Circadian Clock.
DR   Reactome; REACT_25018; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; REACT_25120; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; REACT_25148; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; REACT_25271; Negative regulators of RIG-I/MDA5 signaling.
DR   Reactome; REACT_25325; AUF1 (hnRNP D0) destabilizes mRNA.
DR   Reactome; REACT_25351; TRAF6 mediated induction of TAK1 complex.
DR   Reactome; REACT_25354; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; REACT_25359; RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways.
DR   Reactome; REACT_25374; IKK complex recruitment mediated by RIP1.
DR   Reactome; REACT_25380; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; REACT_263873; degradation of AXIN.
DR   Reactome; REACT_263883; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; REACT_264178; deactivation of the beta-catenin transactivating complex.
DR   Reactome; REACT_264430; Myoclonic epilepsy of Lafora.
DR   Reactome; REACT_264438; degradation of DVL.
DR   Reactome; REACT_264478; Asymmetric localization of PCP proteins.
DR   Reactome; REACT_264580; regulation of FZD by ubiquitination.
DR   Reactome; REACT_264596; TCF dependent signaling in response to WNT.
DR   Reactome; REACT_264605; Hedgehog ligand biogenesis.
DR   Reactome; REACT_267700; Degradation of GLI2 by the proteasome.
DR   Reactome; REACT_268156; Degradation of GLI1 by the proteasome.
DR   Reactome; REACT_268366; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; REACT_268718; Hedgehog 'on' state.
DR   Reactome; REACT_27258; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; REACT_286692; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; REACT_355144; Negative regulation of FGFR3 signaling.
DR   Reactome; REACT_355158; Translesion synthesis by POLK.
DR   Reactome; REACT_355218; Negative regulation of FGFR1 signaling.
DR   Reactome; REACT_355227; Negative regulation of FGFR2 signaling.
DR   Reactome; REACT_355250; Termination of translesion DNA synthesis.
DR   Reactome; REACT_355324; Translesion synthesis by POLI.
DR   Reactome; REACT_355361; Regulation of necroptotic cell death.
DR   Reactome; REACT_355480; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; REACT_355588; Negative regulation of FGFR4 signaling.
DR   Reactome; REACT_4; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; REACT_6359; Budding and maturation of HIV virion.
DR   Reactome; REACT_6761; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; REACT_6785; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; REACT_6818; Assembly Of The HIV Virion.
DR   Reactome; REACT_6820; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; REACT_6821; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; REACT_6850; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; REACT_6871; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; REACT_75776; NOD1/2 Signaling Pathway.
DR   Reactome; REACT_75842; Antigen processing: Ubiquitination & Proteasome degradation.
DR   Reactome; REACT_8; Translesion synthesis by REV1.
DR   Reactome; REACT_8017; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; REACT_821; Cyclin D associated events in G1.
DR   Reactome; REACT_9003; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; REACT_9031; Vpu mediated degradation of CD4.
DR   Reactome; REACT_9453; Vif-mediated degradation of APOBEC3G.
DR   ChiTaRS; UBC; human.
DR   EvolutionaryTrace; P0CG48; -.
DR   GeneWiki; Ubiquitin_C; -.
DR   GenomeRNAi; 7316; -.
DR   NextBio; 33412565; -.
DR   PRO; PR:P0CG48; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; P0CG48; -.
DR   ExpressionAtlas; P0CG48; baseline and differential.
DR   Genevisible; P0CG48; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; TAS:Reactome.
DR   GO; GO:0097190; P:apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:Reactome.
DR   GO; GO:0071456; P:cellular response to hypoxia; TAS:Reactome.
DR   GO; GO:0007623; P:circadian rhythm; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0006281; P:DNA repair; TAS:Reactome.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:Reactome.
DR   GO; GO:0005978; P:glycogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070266; P:necroptotic process; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; TAS:Reactome.
DR   GO; GO:0012501; P:programmed cell death; TAS:Reactome.
DR   GO; GO:0097300; P:programmed necrotic cell death; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0010939; P:regulation of necrotic cell death; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0032479; P:regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome.
DR   GO; GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome.
DR   GO; GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.
DR   GO; GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019082; P:viral protein processing; TAS:Reactome.
DR   GO; GO:0019068; P:virion assembly; TAS:Reactome.
DR   InterPro; IPR019956; Ubiquitin.
DR   InterPro; IPR000626; Ubiquitin-like.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   Pfam; PF00240; ubiquitin; 9.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 9.
DR   SUPFAM; SSF54236; SSF54236; 9.
DR   PROSITE; PS00299; UBIQUITIN_1; 9.
DR   PROSITE; PS50053; UBIQUITIN_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN         1     76       Ubiquitin.
FT                                /FTId=PRO_0000396178.
FT   CHAIN        77    152       Ubiquitin.
FT                                /FTId=PRO_0000396179.
FT   CHAIN       153    228       Ubiquitin.
FT                                /FTId=PRO_0000396180.
FT   CHAIN       229    304       Ubiquitin.
FT                                /FTId=PRO_0000396181.
FT   CHAIN       305    380       Ubiquitin.
FT                                /FTId=PRO_0000396182.
FT   CHAIN       381    456       Ubiquitin.
FT                                /FTId=PRO_0000396183.
FT   CHAIN       457    532       Ubiquitin.
FT                                /FTId=PRO_0000396184.
FT   CHAIN       533    608       Ubiquitin.
FT                                /FTId=PRO_0000396185.
FT   CHAIN       609    684       Ubiquitin.
FT                                /FTId=PRO_0000396186.
FT   PROPEP      685    685
FT                                /FTId=PRO_0000396187.
FT   DOMAIN        1     76       Ubiquitin-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN       77    152       Ubiquitin-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      153    228       Ubiquitin-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      229    304       Ubiquitin-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      305    380       Ubiquitin-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      381    456       Ubiquitin-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      457    532       Ubiquitin-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      533    608       Ubiquitin-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      609    684       Ubiquitin-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   BINDING      54     54       Activating enzyme.
FT   BINDING      72     72       Activating enzyme.
FT   SITE         68     68       Essential for function.
FT   MOD_RES      65     65       Phosphoserine; by PINK1.
FT                                {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582,
FT                                ECO:0000269|PubMed:25527291}.
FT   CROSSLNK      6      6       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603}.
FT   CROSSLNK     11     11       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     27     27       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:15466860}.
FT   CROSSLNK     29     29       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     33     33       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144,
FT                                ECO:0000269|PubMed:17203973}.
FT   CROSSLNK     63     63       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144,
FT                                ECO:0000269|PubMed:18719106}.
FT   CROSSLNK     76     76       Glycyl lysine isopeptide (Gly-Lys)
FT                                (interchain with K-? in acceptor
FT                                proteins).
FT   MUTAGEN      48     48       K->R: No effect on HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      63     63       K->R: Abolishes HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      65     65       S->A: Prevents phosphorylation in case of
FT                                mitophagy. {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582}.
FT   MUTAGEN      65     65       S->D: Phosphomimetic mutant that binds
FT                                and activates PARK2.
FT                                {ECO:0000269|PubMed:24751536}.
FT   CONFLICT    190    190       P -> S (in Ref. 4; AC126309).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       V -> G (in Ref. 6; BAA09860).
FT                                {ECO:0000305}.
FT   STRAND      534    539       {ECO:0000244|PDB:2GBJ}.
FT   STRAND      540    542       {ECO:0000244|PDB:2W9N}.
FT   STRAND      544    548       {ECO:0000244|PDB:2GBM}.
FT   HELIX       555    565       {ECO:0000244|PDB:2GBM}.
FT   STRAND      568    570       {ECO:0000244|PDB:2GBM}.
FT   STRAND      573    577       {ECO:0000244|PDB:3B08}.
FT   STRAND      579    581       {ECO:0000244|PDB:3N3K}.
FT   STRAND      586    588       {ECO:0000244|PDB:1SIF}.
FT   HELIX       589    591       {ECO:0000244|PDB:3B08}.
FT   STRAND      598    603       {ECO:0000244|PDB:3B08}.
FT   STRAND      610    615       {ECO:0000244|PDB:1OGW}.
FT   STRAND      616    618       {ECO:0000244|PDB:4K1R}.
FT   STRAND      620    624       {ECO:0000244|PDB:1OGW}.
FT   STRAND      627    630       {ECO:0000244|PDB:1G6J}.
FT   HELIX       631    642       {ECO:0000244|PDB:1OGW}.
FT   HELIX       646    648       {ECO:0000244|PDB:1OGW}.
FT   STRAND      649    653       {ECO:0000244|PDB:1OGW}.
FT   STRAND      654    657       {ECO:0000244|PDB:4BVU}.
FT   STRAND      660    663       {ECO:0000244|PDB:3JSV}.
FT   HELIX       664    667       {ECO:0000244|PDB:1OGW}.
FT   STRAND      674    679       {ECO:0000244|PDB:1OGW}.
SQ   SEQUENCE   685 AA;  77039 MW;  B6E7BC06FEE77196 CRC64;
     MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ QRLIFAGKQL EDGRTLSDYN
     IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE NVKAKIQDKE GIPPDQQRLI
     FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL TGKTITLEVE PSDTIENVKA
     KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH LVLRLRGGMQ IFVKTLTGKT
     ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED GRTLSDYNIQ KESTLHLVLR
     LRGGMQIFVK TLTGKTITLE VEPSDTIENV KAKIQDKEGI PPDQQRLIFA GKQLEDGRTL
     SDYNIQKEST LHLVLRLRGG MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ
     QRLIFAGKQL EDGRTLSDYN IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE
     NVKAKIQDKE GIPPDQQRLI FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL
     TGKTITLEVE PSDTIENVKA KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH
     LVLRLRGGMQ IFVKTLTGKT ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED
     GRTLSDYNIQ KESTLHLVLR LRGGV
//
